05/18/2026
Final Facts Behind the Cease-and-Desist Notice
This matter is not only about me.
It concerns proprietary health, rehabilitation, occupational mental health, governance, service-delivery, and private-sector incubation work developed over approximately 35 years through philanthropic labour, professional expertise, lived-experience knowledge, personal sacrifice, and private family investment.
This work was not publicly funded. It was not government property. It was not donated, abandoned, or offered as an unrestricted community asset.
It was developed by a law-abiding Canadian, former orphan/ward, senior mental health professional, disabled/vulnerable originator, and private-sector public-benefit innovator whose work has been shaped by surviving the very systems now claiming mandates to assist vulnerable people.
My daughter and heir has also carried the burden of this work and its losses alongside me. She is a leukemia-affected young professional and co-grievor in the broader pattern of institutional delay, exclusion, and harm affecting our family, corporation, and future.
Around August 2023, I shared proprietary business-development information and health-incubator concepts in good faith with PACE-related, Chamber-related, municipal, public-sector, Indigenous-facing, nonprofit, and/or community economic-development actors. I did so in the spirit of collaboration, partnership, and public-benefit development.
My rollout was slowed by medical trauma, ignored clinical hypotheses, employment-related harm, disability-related barriers, and public-sector process. Those delays did not transfer ownership, waive my rights, or authorize others to advance overlapping or derivative concepts while excluding my clinic and corporation.
Many other entities and stakeholders have interests in these outcomes: collaborators, prior NDA-connected parties, co-development interests, referral systems, professional networks, injured workers, disadvantaged Canadians, private-sector partners, and service users who were meant to benefit from the original mandate.
My concern is that proprietary or co-developed material may have been accessed, adapted, incubated, circulated, or advanced without consent, attribution, licensing, compensation, procurement fairness, conflict-of-interest protection, or fair participation by the originating clinic and corporation.
I am further concerned that public-sector or publicly funded actors, including program supervisors, may have facilitated, tolerated, or failed to prevent the contamination of my corporate rights, declared conflict-of-interest protections, procurement integrity, and competition fairness.
This is not the first time I believe and documentatu9n at law exists showing my work, insight, or vulnerability has been mined. It is the first time I have had enough prior protections and documentation, capacity, public-facing evidence, and timing to preserve the record and identify the pattern clearly.
The issue is not only what may have been taken.
It is who it was taken from.
It is how the originator was mischaracterized.
It is who was allowed to benefit.
It is whether authorities and organizations mandated to assist vulnerable people instead participated in, tolerated, or benefited from excluding a vulnerable originator from the value of her own work.
Relevant parties are now on notice.
Cease unauthorized use. Preserve all records. Do not delete, alter, conceal, transfer, reframe, or continue using derivative material.
Formal legal notices and related service steps are being prepared regarding suspected intellectual-property theft, breach of confidence, procurement-integrity breaches, competition-law concerns, conflict-of-interest contamination, reputational harm, unjust enrichment, and damages to me, my daughter, my corporation, and affected stakeholders.
This is now a legal, governance, procurement-integrity, conflict-of-interest, and public-accountability matter.
